Ultralife Balans Gezondheid

Financiële gezondheid criteriumcontroles 6/6

Ultralife heeft een totaal eigen vermogen van $134.6M en een totale schuld van $7.9M, wat de schuld-eigenvermogensverhouding op 5.9% brengt. De totale activa en totale passiva bedragen respectievelijk $172.4M en $37.8M. De EBIT Ultralife is $12.4M waardoor de rentedekking 7.4 is. Het heeft contanten en kortetermijnbeleggingen van $6.8M.

Belangrijke informatie

5.9%

Verhouding schuld/eigen vermogen

US$7.89m

Schuld

Rente dekkingsratio	7.4x
Contant	US$6.77m
Aandelen	US$134.63m
Totaal verplichtingen	US$37.81m
Totaal activa	US$172.44m

Recente financiële gezondheidsupdates

These 4 Measures Indicate That Ultralife (NASDAQ:ULBI) Is Using Debt Reasonably Well

Apr 16

Recent updates

Should You Think About Buying Ultralife Corporation (NASDAQ:ULBI) Now?

Sep 07

Ultralife: I Bought The Dip; Here Comes The Growth

Aug 03

Ultralife's (NASDAQ:ULBI) Earnings Are Weaker Than They Seem

Aug 01

Ultralife Corporation Is Attractive Here

Jun 30

Ultralife Corporation: Ready To Surge

Apr 22

These 4 Measures Indicate That Ultralife (NASDAQ:ULBI) Is Using Debt Reasonably Well

Apr 16

Slowing Rates Of Return At Ultralife (NASDAQ:ULBI) Leave Little Room For Excitement

Mar 14

Insufficient Growth At Ultralife Corporation (NASDAQ:ULBI) Hampers Share Price

Feb 11

Is Now An Opportune Moment To Examine Ultralife Corporation (NASDAQ:ULBI)?

Oct 26

Ultralife (NASDAQ:ULBI) May Have Issues Allocating Its Capital

Sep 22

Ultralife (NASDAQ:ULBI) Takes On Some Risk With Its Use Of Debt

Jun 08

Ultralife (NASDAQ:ULBI) Is Carrying A Fair Bit Of Debt

Sep 27

Ultralife secures $7.5M communications systems contract

Sep 22

Ultralife receives $4.6M communications systems VAA order

Jul 26

Does Ultralife (NASDAQ:ULBI) Have A Healthy Balance Sheet?

Apr 15

We Think Ultralife Corporation's (NASDAQ:ULBI) CEO Compensation Package Needs To Be Put Under A Microscope

Jul 15

Is Ultralife Corporation (NASDAQ:ULBI) Potentially Undervalued?

Apr 14

The Trends At Ultralife (NASDAQ:ULBI) That You Should Know About

Mar 09

Ultralife Corporation's (NASDAQ:ULBI) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?

Feb 18

Ultralife reports Q4 results

Feb 04

If You Had Bought Ultralife (NASDAQ:ULBI) Stock Five Years Ago, You Could Pocket A 17% Gain Today

Feb 03

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( $86.4M ) ULBI } overtreffen de korte termijn passiva ( $26.2M ).

Langlopende schulden: De kortetermijnactiva ULBI ( $86.4M ) overtreffen de langetermijnschulden ( $11.6M ).

Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: De netto schuld/eigen vermogen ratio ( 0.8% ) ULBI wordt als voldoende beschouwd.

Schuld verminderen: De schuld/eigen vermogen-ratio van ULBI is de afgelopen 5 jaar gedaald van 16.4% naar 5.9%.

Schuldendekking: De schuld van ULBI wordt goed gedekt door de operationele kasstroom ( 203.1% ).

Rentedekking: De rentebetalingen op de schuld van ULBI worden goed gedekt door EBIT ( 7.4 x dekking).

Ultralife Balans Gezondheid

Financiële gezondheid criteriumcontroles 6/6

Belangrijke informatie

Recente financiële gezondheidsupdates

These 4 Measures Indicate That Ultralife (NASDAQ:ULBI) Is Using Debt Reasonably Well

Ultralife (NASDAQ:ULBI) Takes On Some Risk With Its Use Of Debt

Ultralife (NASDAQ:ULBI) Is Carrying A Fair Bit Of Debt

Does Ultralife (NASDAQ:ULBI) Have A Healthy Balance Sheet?

Recent updates

Ultralife Corporation to Report Q3, 2024 Results on Nov 08, 2024

Ultralife Corporation (NasdaqGM:ULBI) signed a stock purchase agreement to acquire Electrochem Solutions, Inc. from Integer Holdings Corporation (NYSE:ITGR) for $50 million.

Should You Think About Buying Ultralife Corporation (NASDAQ:ULBI) Now?

Ultralife: I Bought The Dip; Here Comes The Growth

Ultralife's (NASDAQ:ULBI) Earnings Are Weaker Than They Seem

Ultralife Corporation to Report Q2, 2024 Results on Jul 25, 2024

Ultralife Corporation Is Attractive Here

Ultralife Corporation, Annual General Meeting, Jul 16, 2024

Investor sentiment improves as stock rises 17%

Price target decreased by 7.7% to US$12.00

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

Ultralife Corporation: Ready To Surge

These 4 Measures Indicate That Ultralife (NASDAQ:ULBI) Is Using Debt Reasonably Well

Ultralife Corporation to Report Q1, 2024 Results on Apr 25, 2024

Full year 2023 earnings released: EPS: US$0.44 (vs US$0.007 loss in FY 2022)

Slowing Rates Of Return At Ultralife (NASDAQ:ULBI) Leave Little Room For Excitement

Full year 2023 earnings released: EPS: US$0.44 (vs US$0.007 loss in FY 2022)

Investor sentiment improves as stock rises 15%

Insufficient Growth At Ultralife Corporation (NASDAQ:ULBI) Hampers Share Price

New major risk - Revenue and earnings growth

Ultralife Corporation to Report Q4, 2023 Results on Feb 15, 2024

Independent Chairman recently bought US$111k worth of stock

Independent Chairman recently bought US$181k worth of stock

Independent Chairman recently bought US$99k worth of stock

Investor sentiment deteriorates as stock falls 19%

Third quarter 2023 earnings: Revenues and EPS in line with analyst expectations

Is Now An Opportune Moment To Examine Ultralife Corporation (NASDAQ:ULBI)?

Ultralife Corporation to Report Q3, 2023 Results on Oct 26, 2023

Investor sentiment improves as stock rises 18%

Ultralife (NASDAQ:ULBI) May Have Issues Allocating Its Capital

Independent Chairman recently bought US$112k worth of stock

Investor sentiment improves as stock rises 27%

Consensus revenue estimates increase by 12%

New major risk - Share price stability

Second quarter 2023 earnings: EPS and revenues exceed analyst expectations

Ultralife Corporation to Report Q2, 2023 Results on Jul 27, 2023

Independent Chairman recently bought US$398k worth of stock

Ultralife (NASDAQ:ULBI) Takes On Some Risk With Its Use Of Debt

Independent Chairman recently bought US$146k worth of stock

Ultralife Corporation, Annual General Meeting, Jul 19, 2023

Independent Chairman recently bought US$117k worth of stock

Full year 2022 earnings released: US$0.007 loss per share (vs US$0.015 loss in FY 2021)

Independent Chairman recently bought US$122k worth of stock

Full year 2022 earnings released: US$0.007 loss per share (vs US$0.015 loss in FY 2021)

Independent Chairman recently bought US$279k worth of stock

Ultralife Corporation Announces Executive Changes

Price target increased to US$12.00

Insufficient new directors

Third quarter 2022 earnings: EPS misses analyst expectations

Ultralife Corporation to Report Q3, 2022 Results on Oct 27, 2022

Ultralife (NASDAQ:ULBI) Is Carrying A Fair Bit Of Debt

Ultralife secures $7.5M communications systems contract

Independent Chairman recently bought US$158k worth of stock

Independent Chairman recently bought US$467k worth of stock

Second quarter 2022 earnings: EPS and revenues exceed analyst expectations

Ultralife receives $4.6M communications systems VAA order

Ultralife Corporation to Report Q2, 2022 Results on Jul 28, 2022

Independent Chairman recently bought US$219k worth of stock

Ultralife Corporation, Annual General Meeting, Jul 20, 2022

First quarter 2022 earnings: EPS and revenues exceed analyst expectations

Insufficient new directors

Ultralife Corporation to Report Q1, 2022 Results on Apr 28, 2022

Does Ultralife (NASDAQ:ULBI) Have A Healthy Balance Sheet?

Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behind

Independent Chairman recently bought US$245k worth of stock

Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behind

Consensus revenue estimates fall by 14%

Investor sentiment improved over the past week

Ultralife Corporation (NasdaqGM:ULBI) acquired Excell Battery Company for $23.5 million.

Third quarter 2021 earnings released: US$0.036 loss per share (vs US$0.026 profit in 3Q 2020)

Independent Chairman recently bought US$199k worth of stock